Vertex Pharmaceuticals Goodwill and Intangible Assets 2010-2024 | VRTX

Vertex Pharmaceuticals goodwill and intangible assets for the quarter ending December 31, 2024 were $1.914B, a 0.73% decline year-over-year.

  • Vertex Pharmaceuticals goodwill and intangible assets for 2024 were $1.914B, a 0.73% decline from 2023.
  • Vertex Pharmaceuticals goodwill and intangible assets for 2023 were $1.928B, a 13.97% increase from 2022.
  • Vertex Pharmaceuticals goodwill and intangible assets for 2022 were $1.692B, a 20.64% increase from 2021.

Vertex Pharmaceuticals Goodwill and Intangible Assets 2010-2024 | VRTX

  • Vertex Pharmaceuticals goodwill and intangible assets for 2024 were $1.914B, a 0.73% decline from 2023.
  • Vertex Pharmaceuticals goodwill and intangible assets for 2023 were $1.928B, a 13.97% increase from 2022.
  • Vertex Pharmaceuticals goodwill and intangible assets for 2022 were $1.692B, a 20.64% increase from 2021.